Supply of the medicinal product Nintedanib under drug programmes B.87 and B.135

Summary

The tender concerns the supply of the medicinal product Nintedanib under drug programmes B.87 and B.135: 230 packs of 100 mg capsules, 60 capsules per pack, and 220 packs of 150 mg capsules, 60 capsules per pack. The contract period is 6 months and no partial bids or options are provided. Price is the only award criterion, weighted at 100%. Offers must be submitted electronically through the contracting authority’s procurement platform by 15 September 2026 at 08:00, using a qualified electronic signature, trusted signature or personal signature. The tenderer must also submit the required declaration and evidence of wholesale distribution authorisation for medicinal products.